Expression levels of human P-glycoprotein in in vitro cell lines: Correlation between mRNA and protein levels for P-glycoprotein expressed in cells

Biopharmaceutics and Drug Disposition

Volumn 30, Issue 3, 2009, Pages 149-152

  Shirasaka, Yoshiyuki ^a,b   Konishi, Reiko ^a,c   Funami, Nana ^a   Kadowaki, Yuko ^a,c   Nagai, Yuri ^a   Sakaeda, Toshiyuki ^c,d   Yamashita, Shinji ^a  

^a SETSUNAN UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c KOBE UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Caco 2 cells; Expression level; MDCKII MDR1 cells; MDR1; P glycoprotein

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN CACO 2; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOLAYER CULTURE; MULTIDRUG RESISTANCE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; VALIDATION PROCESS;

ANIMALS; BLOTTING, WESTERN; CACO-2 CELLS; DOGS; EPITHELIAL CELLS; HUMANS; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VINBLASTINE;

EID: 65549095353     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.650     Document Type: Article

References (13)

1. Hunter J, Hirst BH. Intestinal secretion of drugs: The role of P-glycoprotein and related drug efflux systems in limiting oral drug absorption. Adv Drug Del Rev 1997; 25: 129-157.
2. Kikuchi A, Nozawa T, Wakasawa T, Maeda T, Tamai I. Transporter-mediated intestinal absorption of fexofenadine in rats. Drug Metab Pharmacokinet 2006; 21: 308-314.
3. Shirasaka Y, Li Y, Shibue Y, et al. Concentration-dependent effect of naringin on intestinal absorption of b1-adrenoceptor antagonist talinolol mediated by P-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res 2009; 26: 560-567.
4. Morimoto K, Nakakariya M, Shirasaka Y, et al. Oseltamivir (Tamiflu) efflux transport at the blood-brain barrier via P-glycoprotein. Drug Metab Dispos 2008; 36: 6-9.
5. González-Alvarez I, Fernández-Teruel C, Casabó-Alós VG et al. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results. Biopharm Drug Dispos 2007; 28: 229-239.
6. Polli JW, Wring SA, Humphreys JE, et al. Rational use of in vitro P-glycoprotein assays in drug discovery. J Pharmacol Exp Ther 2001; 299: 620-628.
7. Shirasaka Y, Onishi Y, Sakurai A, Nakagawa H, Ishikawa T, Yamashita S. Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs. Biol Pharm Bull 2006; 29: 2465-2471.
8. Shirasaka Y, Kawasaki M, Sakane T, et al. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport. Drug Metab Pharmacokinet 2006; 21: 414-423.
9. Watanabe T, Onuki R, Yamashita S, Taira K, Sugiyama Y. Construction of a functional transporter analysis system using MDR1 knockdown Caco-2 cells. Pharm Res 2005; 22: 1287-1293.
10. Troutman MD, Thakker DR. Novel experimental parameters to quantify the modulation of absorptive and secretory transport of compounds by P-glycoprotein in cell culture models of intestinal epithelium. Pharm Res 2003; 20: 1210-1224.
11. Shirasaka Y, Sakane T, Yamashita S. Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane. J Pharm Sci 2008; 97: 553-565.
12. Shirasaka Y, Masaoka Y, Kataoka M, Sakuma S, Yamashita S. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo. Pharm Res 2008; 36: 916-922.
13. Yamashita S, Konishi K, Yamazaki Y, et al. New and better protocols for a short-term Caco-2 cell culture system. J Pharm Sci 2002; 91: 669-679.